Interleukin 28B Polymorphism Predicts Treatment Outcome Among Egyptian Patients Infected With HCV Genotype 4.
Mahmoud El-BendaryMustafa A NeamatallahMohamed Abd El-MaksoudMaha AminPublished in: Hepato-gastroenterology (2016)
The IL28B rs12979860 SNP is the strongest predictor of an SVR among Egyptian patients infected with HCV-4.